Certara
Certara offers model-informed drug-development services and biosimulation software. Its public portfolio includes Phoenix for PK/PD analysis and Simcyp for PBPK modeling, alongside development and regulatory support. Software availability does not establish a model's fitness for a particular decision.
Corporate information
- Company entity
- Certara
- Headquarters / principal office
- Radnor, Pennsylvania, United States ↗
- Founded
- 2008 ↗
- Ownership / capital status
- Publicly tradedNasdaq CERT ↗
- Official corporate reference
- https://www.certara.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Start with public sources and capability boundaries; company claims are not independent certification.
Ask AI ↗Public evidence snapshot
Certara offers model-informed drug-development services and biosimulation software. Its public portfolio includes Phoenix for PK/PD analysis and Simcyp for PBPK modeling, alongside development and regulatory support. Software availability does not establish a model's fitness for a particular decision.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- Certara — official website
- Explicit company formation history
- Corporate headquarters disclosure
- Official investor FAQ / exchange listing